170 related articles for article (PubMed ID: 38617351)
1. Axonal organelle buildup from loss of AP-4 complex function causes exacerbation of amyloid plaque pathology and gliosis in Alzheimer's disease mouse model.
Orlowski A; Karippaparambil J; Paumier JM; Ghanta S; Pallares E; Tandukar J; Gao R; Gowrishankar S
bioRxiv; 2024 Apr; ():. PubMed ID: 38617351
[TBL] [Abstract][Full Text] [Related]
2. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology.
Gowrishankar S; Wu Y; Ferguson SM
J Cell Biol; 2017 Oct; 216(10):3291-3305. PubMed ID: 28784610
[TBL] [Abstract][Full Text] [Related]
3. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.
Gowrishankar S; Yuan P; Wu Y; Schrag M; Paradise S; Grutzendler J; De Camilli P; Ferguson SM
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):E3699-708. PubMed ID: 26124111
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
[TBL] [Abstract][Full Text] [Related]
5. AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network.
Majumder P; Edmison D; Rodger C; Patel S; Reid E; Gowrishankar S
Mol Biol Cell; 2022 Oct; 33(12):ar102. PubMed ID: 35976706
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
7. AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons.
Bera S; Camblor-Perujo S; Calleja Barca E; Negrete-Hurtado A; Racho J; De Bruyckere E; Wittich C; Ellrich N; Martins S; Adjaye J; Kononenko NL
EMBO Rep; 2020 Jun; 21(6):e47954. PubMed ID: 32323475
[TBL] [Abstract][Full Text] [Related]
8. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
[TBL] [Abstract][Full Text] [Related]
9. The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.
Kandalepas PC; Sadleir KR; Eimer WA; Zhao J; Nicholson DA; Vassar R
Acta Neuropathol; 2013 Sep; 126(3):329-52. PubMed ID: 23820808
[TBL] [Abstract][Full Text] [Related]
10. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.
Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX
Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570
[TBL] [Abstract][Full Text] [Related]
11. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.
Sanchez-Varo R; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; De Castro V; Jimenez S; Ruano D; Vizuete M; Davila JC; Garcia-Verdugo JM; Jimenez AJ; Vitorica J; Gutierrez A
Acta Neuropathol; 2012 Jan; 123(1):53-70. PubMed ID: 22020633
[TBL] [Abstract][Full Text] [Related]
12. Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
Peters F; Salihoglu H; Pratsch K; Herzog E; Pigoni M; Sgobio C; Lichtenthaler SF; Neumann U; Herms J
EMBO J; 2019 Dec; 38(23):e102345. PubMed ID: 31701556
[TBL] [Abstract][Full Text] [Related]
13.
Lomoio S; Willen R; Kim W; Ho KZ; Robinson EK; Prokopenko D; Kennedy ME; Tanzi RE; Tesco G
Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208500
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
15. Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?
Yan XX; Ma C; Gai WP; Cai H; Luo XG
J Alzheimers Dis; 2014; 38(4):705-18. PubMed ID: 24081378
[TBL] [Abstract][Full Text] [Related]
16. Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation.
Feng T; Tammineni P; Agrawal C; Jeong YY; Cai Q
J Biol Chem; 2017 Feb; 292(5):1679-1690. PubMed ID: 28028177
[TBL] [Abstract][Full Text] [Related]
17. Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.
Rodrigues EM; Weissmiller AM; Goldstein LS
Hum Mol Genet; 2012 Nov; 21(21):4587-601. PubMed ID: 22843498
[TBL] [Abstract][Full Text] [Related]
18. Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.
Chaves RS; Tran M; Holder AR; Balcer AM; Dickey AM; Roberts EA; Bober BG; Gutierrez E; Head BP; Groisman A; Goldstein LSB; Almenar-Queralt A; Shah SB
J Neurosci; 2021 Dec; 41(49):10034-10053. PubMed ID: 34663629
[TBL] [Abstract][Full Text] [Related]
19. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus.
Torres M; Jimenez S; Sanchez-Varo R; Navarro V; Trujillo-Estrada L; Sanchez-Mejias E; Carmona I; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Mol Neurodegener; 2012 Nov; 7():59. PubMed ID: 23173743
[TBL] [Abstract][Full Text] [Related]
20. UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.
Almenar-Queralt A; Falzone TL; Shen Z; Lillo C; Killian RL; Arreola AS; Niederst ED; Ng KS; Kim SN; Briggs SP; Williams DS; Goldstein LS
J Neurosci; 2014 Feb; 34(9):3320-39. PubMed ID: 24573290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
